Key Takeaways:
📞 Call (754) 331-6379 | In-Person & Telehealth Appointments Available
Semaglutide, marketed under the brand names Ozempic and Wegovy, is an effective medication for the treatment of type 2 diabetes and obesity. For individuals residing in South Florida seeking to obtain Semaglutide, it is essential to understand the eligibility criteria, its associated cost, and the role of insurance coverage.

Semaglutide is an FDA-approved, once-weekly prescription for adult weight management. As a GLP-1 agonist, it helps control appetite, slow stomach emptying, and improve insulin sensitivity—promoting lasting fullness, reduced cravings, and effective weight loss. Popular brands include Wegovy, Ozempic, and Saxenda.

To be eligible for Semaglutide, patients must have a diagnosis of either type 2 diabetes or obesity. In the case of type 2 diabetes, it is generally prescribed to those whose blood sugar levels remain uncontrolled despite other medications or lifestyle modifications. For obesity, Semaglutide is indicated for individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher alongside a weight-related health condition.
Dr. Terushkin offers competitive rates for GLP – 1 agonists (Semaglutide) injections:
Disclaimer: Dosage and pricing may vary based on medical evaluation. Please call us for more information.
Insurance accepted – or pay out-of-pocket with flexible self-pay options for affordable access to medical weight loss care.
Insurance coverage for these medications may vary, especially for patients with obesity-related health conditions. Dr. Terushkin’s staff is available to assist with insurance inquiries and maximize benefits.

Patients opting for self-pay will be responsible for the above costs, providing flexibility in payment based on treatment duration and frequency.

Insurance coverage plays a crucial role in obtaining Semaglutide. Patients should consult their insurance providers to determine if Semaglutide is covered under their plan and what costs they may be responsible for. Some insurance plans may require prior authorization or step therapy, meaning patients might need to try other treatments before being eligible for Semaglutide.
📞 Call (754) 331-6379 | In-Person & Telehealth Appointments Available

Patients in South Florida interested in Semaglutide should confirm medical eligibility and check insurance coverage or assistance programs to reduce costs. Consulting with insurers helps clarify coverage and steps to access the medication for managing type 2 diabetes or obesity.
Useful Links